Methylprednisolone and hydrocortisone sodium succinate treatment of bronchial asthma at acute observation of the early.doc

 PAGE \* MERGEFORMAT 8 Methylprednisolone and hydrocortisone sodium succinate treatment of bronchial asthma at acute observation of the early [Abstract] Objective To compare methylprednisolone and hydrocortisone sodium succinate treatment of bronchial asthma at acute stage of early treatment. Methods 40 patients with severe bronchial asthma were divided into two groups, methylprednisolone group and the hydrocortisone group, 20 cases. methylprednisolone were given intravenous methylprednisolone 40mg q12h, were given hydrocortisone hydrocortisone sodium succinate 200mg q12h treatment, observation of 3 days, and compare the results. result there methylprednisolone group efficiency of 95%, hydrocortisone sodium succinate (H test) total effective rate was 80%, showed no significant difference, Pgt; 0. 05. Conclusion methylprednisolone and hydrocortisone sodium succinate early no significant difference in efficacy. [Keywords:] bronchial asthma; methylprednisolone; hydrocortisone sodium succinate Bronchial asthma (bronchial asthma, referred to as asthma) is a combination of cells (such as eosinophils, mast cells and T lymphocytes, neutrophils, airway epithelial cells) and cellular components involved in chronic inflammatory airway disease. This chronic inflammatory response lead to increased airway is usually reversible with widespread variable airflow limitation, and cause recurrent episodes of wheezing, shortness of breath or cough and other symptoms, the feeling, often at night and (or) early morning attack, intensified, most patients can be treated self-mitigation or remission [1]. bronchial asthma can be divided into acute attack and non-acute attack. bronchodilator treatment of drugs, including drugs (2 adrenergic agonists, anticholinergic drugs and Theophylline), anti-inflammatory drugs (corticosteroids, leukotriene agents). glucocorticoid which is currently the most effective control of asthma drugs, it is divided into inhalation, oral and intravenous